Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


ReproFF2: Feeder-Free & Weekend-Labor-Free Medium

Product Description
Culture maintenance required only three days/week
Halves the amount of media use
Reduce the labor cost for the weekend
Maintains stable undifferentiated state
Maintains robust differentiation capability

ReproFF2 is a new, improved feeder-free medium for human ES/iPS cells. Unlike conventional culture media that requires changing on a daily basis, ReproFF2 needs culture maintenance only three days a week, with no compromise made to the quality of the cells. Change the medium on Monday and Wednesday, passage the cells on Friday. Consequently, the cost and amount of medium used are halved, feeder cells need not be prepared, and the culture need not be cared during the weekend.

ReproFF2 was developed in collaboration with leading stem cell scientists for trouble-free, reproducible maintenance of ES and iPS cells. ReproFF2 has been developed to reduce the number of steps in the workflow and is in a highly convenient ready-to-go formulation. Just warm up, add bFGF*, and ReproFF2 is ready.
Product ReproFF2: Feeder-Free & Weekend-Labor-Free Medium
Company ReproCell Products
Price Request a quote
More Information View company product page
Catalog Number RCHEMD006
Quantity 500 mL
Company Logo

ReproCell Products
Reprocell Inc KDX Shin-yokohama 381 Bldg 8F 3-8-11, Shin-yokohama, Kohoku-ku, Yokohama Kanagawa 222-0033, Japan

Tel: +81 45-475-3887
Fax: +81 45-474-1006
Email: info_repro@reprocell.com



Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!